Truist Financial Maintains Pacira BioSciences(PCRX.US) With Sell Rating
Are Options Traders Betting on a Big Move in Pacira BioSciences (PCRX) Stock?
Press Release: Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Fly 27% But Investors Aren't Buying For Growth
The Three-year Loss for Pacira BioSciences (NASDAQ:PCRX) Shareholders Likely Driven by Its Shrinking Earnings
Express News | RBC Capital Maintains Sector Perform on Pacira BioSciences, Raises Price Target to $15
Does Pacira BioSciences (NASDAQ:PCRX) Have A Healthy Balance Sheet?
Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
Executive Reshuffles: NSC, PCRX and OMI Companies in Focus
Pacira BioSciences Appoints Lauren Riker as Interim CFO
Express News | Pacira Biosciences Inc: Board Appointed Lauren Riker as Interim Chief Financial Officer
Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
Pacira BioSciences Urged to 'Aggressively' Buy Back Shares to Enhance Return
DOMA Perpetual Sends Letter To Board of Directors Of Pacira Biosciences To Immediately Accelerate And Increase Its Share Buyback Program To Enhance Return To Shareholders; Believes Pacira's Cash Balance Of $400M, Roughly 59% of Its Market...
Express News | Doma Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase Its Share Buyback Program to Enhance Return to Shareholders
Jefferies Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Cuts Target Price to $18
Jefferies & Co Adjusts Pacira BioSciences Price Target to $18 From $15, Maintains Buy Rating
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma
Lacklustre Performance Is Driving Pacira BioSciences, Inc.'s (NASDAQ:PCRX) 26% Price Drop